vs
National Healthcare Properties, Inc.（NHPAP）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
National Healthcare Properties, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$84.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -3.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -2.2%）
本公司是一家总部位于英国伦敦的房地产投资企业，核心业务为投资运营基础医疗设施。截至2025年6月，公司在英国和爱尔兰拥有并运营超过500家基础医疗机构，目前在伦敦证券交易所上市，是富时250指数的成分股之一。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NHPAP vs PBYI — 直观对比
营收规模更大
NHPAP
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出31.4%
-3.7%
两年增速更快
PBYI
近两年复合增速
-2.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $84.5M | $75.5M |
| 净利润 | $-22.8M | — |
| 毛利率 | 36.5% | 69.3% |
| 营业利润率 | -7.8% | 22.7% |
| 净利率 | -27.0% | — |
| 营收同比 | -3.7% | 27.7% |
| 净利润同比 | -33.9% | — |
| 每股收益（稀释后） | $-0.92 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NHPAPPBYI
| Q4 25 | $84.5M | $75.5M | ||
| Q3 25 | $86.0M | $54.5M | ||
| Q2 25 | $85.3M | $52.4M | ||
| Q1 25 | $86.4M | $46.0M | ||
| Q4 24 | $87.7M | $59.1M | ||
| Q3 24 | $88.9M | $80.5M | ||
| Q2 24 | $88.8M | $47.1M | ||
| Q1 24 | $88.3M | $43.8M |
净利润NHPAPPBYI
| Q4 25 | $-22.8M | — | ||
| Q3 25 | $-12.5M | $8.8M | ||
| Q2 25 | $-20.8M | $5.9M | ||
| Q1 25 | $-1.5M | $3.0M | ||
| Q4 24 | $-17.0M | — | ||
| Q3 24 | $-40.8M | $20.3M | ||
| Q2 24 | $-116.9M | $-4.5M | ||
| Q1 24 | $-15.6M | $-4.8M |
毛利率NHPAPPBYI
| Q4 25 | 36.5% | 69.3% | ||
| Q3 25 | 37.4% | 77.7% | ||
| Q2 25 | 36.9% | 76.5% | ||
| Q1 25 | 33.4% | 77.1% | ||
| Q4 24 | 37.4% | 76.4% | ||
| Q3 24 | 36.6% | 63.9% | ||
| Q2 24 | 38.1% | 77.4% | ||
| Q1 24 | 37.5% | 75.5% |
营业利润率NHPAPPBYI
| Q4 25 | -7.8% | 22.7% | ||
| Q3 25 | 2.8% | 17.6% | ||
| Q2 25 | -6.5% | 12.7% | ||
| Q1 25 | 15.1% | 8.7% | ||
| Q4 24 | -1.2% | 22.6% | ||
| Q3 24 | -23.5% | 27.4% | ||
| Q2 24 | -113.1% | -4.6% | ||
| Q1 24 | -1.3% | -5.3% |
净利率NHPAPPBYI
| Q4 25 | -27.0% | — | ||
| Q3 25 | -14.6% | 16.2% | ||
| Q2 25 | -24.4% | 11.2% | ||
| Q1 25 | -1.8% | 6.5% | ||
| Q4 24 | -19.4% | — | ||
| Q3 24 | -45.8% | 25.2% | ||
| Q2 24 | -131.6% | -9.6% | ||
| Q1 24 | -17.6% | -11.0% |
每股收益（稀释后）NHPAPPBYI
| Q4 25 | $-0.92 | $0.26 | ||
| Q3 25 | $-0.56 | $0.17 | ||
| Q2 25 | $-0.85 | $0.12 | ||
| Q1 25 | $-0.18 | $0.06 | ||
| Q4 24 | $-0.72 | $0.40 | ||
| Q3 24 | $-1.56 | $0.41 | ||
| Q2 24 | $-4.24 | $-0.09 | ||
| Q1 24 | $-0.67 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $600.1M | $130.3M |
| 总资产 | $1.7B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NHPAPPBYI
| Q4 25 | $57.6M | $97.5M | ||
| Q3 25 | $47.1M | $94.4M | ||
| Q2 25 | $47.1M | $96.0M | ||
| Q1 25 | $71.4M | $93.2M | ||
| Q4 24 | $21.7M | $101.0M | ||
| Q3 24 | $32.9M | $96.7M | ||
| Q2 24 | $29.5M | $96.8M | ||
| Q1 24 | $28.7M | $107.2M |
总债务NHPAPPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NHPAPPBYI
| Q4 25 | $600.1M | $130.3M | ||
| Q3 25 | $627.2M | $115.3M | ||
| Q2 25 | $647.0M | $104.7M | ||
| Q1 25 | $674.6M | $97.1M | ||
| Q4 24 | $684.6M | $92.1M | ||
| Q3 24 | $702.6M | $71.1M | ||
| Q2 24 | $756.7M | $48.5M | ||
| Q1 24 | $877.7M | $51.0M |
总资产NHPAPPBYI
| Q4 25 | $1.7B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.8B | $194.9M | ||
| Q1 25 | $1.8B | $196.2M | ||
| Q4 24 | $1.9B | $213.3M | ||
| Q3 24 | $2.0B | $220.7M | ||
| Q2 24 | $2.1B | $205.0M | ||
| Q1 24 | $2.1B | $214.1M |
负债/权益比NHPAPPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NHPAPPBYI
| Q4 25 | $7.0M | $14.4M | ||
| Q3 25 | $10.2M | $9.7M | ||
| Q2 25 | $8.1M | $14.1M | ||
| Q1 25 | $-21.2M | $3.6M | ||
| Q4 24 | $-79.8M | $15.6M | ||
| Q3 24 | $-95.2M | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $2.5M | $11.2M |
自由现金流NHPAPPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率NHPAPPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度NHPAPPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率NHPAPPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NHPAP
| Seniors Housing Communities | $56.3M | 67% |
| Outpatient Medical Facilities | $28.1M | 33% |
PBYI
暂无分部数据
